首页> 外国专利> COMPOSITION FOR ANTI-CANCER AND IMMUNE ENHANCEMENT, WHICH INDUCES ACTIVATION OF NATURAL KILLER CELLS, IMMUNOGLOBULIN, AND MACROPHAGE

COMPOSITION FOR ANTI-CANCER AND IMMUNE ENHANCEMENT, WHICH INDUCES ACTIVATION OF NATURAL KILLER CELLS, IMMUNOGLOBULIN, AND MACROPHAGE

机译:用于诱导天然杀伤细胞,免疫球蛋白和巨噬细胞活化的抗癌和免疫增强组合物

摘要

PURPOSE: A composition containing branched-chain amino acid(BCAA) and Lactobacillus brevis is provide to ensure immunity enhancement, anti-cancer, and growth promotion.;CONSTITUTION: A composition for anti-cancer and immunity enhancement contains 0.5-10 wt% of Lactobacillus brevis having as activity of suppressing cancer cell line, 0.5-3.0 wt% of galactooligosaccharides which enhances Lactobacillus brevis activity, 0.1-2.0 wt% of beta-glucan enhancing immunity, and 0.5-5.0 wt% of L-valine of branched-chain amino acids(BCAA) for helping growth. The composition is manufactured in the form of a capsule, liquid, tablet, powder, granule, or pill.;COPYRIGHT KIPO 2012
机译:目的:提供一种包含支链氨基酸(BCAA)和短乳杆菌的组合物,以确保增强免疫力,抗癌和促进生长。;组成:用于抗癌和免疫力增强的组合物包含0.5-10 wt%的短乳杆菌具有抑制癌细胞系的活性,其中0.5-3.0 wt%的可增强短乳杆菌活性的低聚半乳糖,0.1-2.0 wt%的增强免疫力的β-葡聚糖,以及0.5-5.0 wt%的支链L-缬氨酸氨基酸(BCAA)有助于生长。该组合物以胶囊剂,液体剂,片剂,粉剂,颗粒剂或丸剂的形式制造。COPYRIGHTKIPO 2012

著录项

  • 公开/公告号KR20110117277A

    专利类型

  • 公开/公告日2011-10-27

    原文格式PDF

  • 申请/专利权人 NKBIO CO. LTD.;

    申请/专利号KR20100036644

  • 发明设计人 KIM SU DONG;KIM SOO KI;LEE JIN YONG;

    申请日2010-04-21

  • 分类号A61K31/7088;A61K31/716;A61K39/02;A61P35/00;

  • 国家 KR

  • 入库时间 2022-08-21 17:50:50

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号